Trial intelligence / Profile preview

Population Pharmacokinetics of Ethambutol in Overweight and Obese Volunteers

NCT01048697Phase 4Completed

Sponsor
Texas Tech University Health Sciences Center
Start
Jan 2010
Primary completion
Dec 2010
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label, single-arm trial of ethambutol in Tuberculosis (TB), sponsored by Texas Tech University Health Sciences Center. Primary endpoint: Total Clearance of Ethambutol at 24 hours. Started Jan 2010; status: completed.

02

Drugs

ethambutol
03

Conditions

Tuberculosis (TB)

Beyond the preview

Go deeper on NCT01048697.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01048697.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call